BRIEF published on 01/13/2025 at 09:35, 1 year 3 months ago Fleury Michon: Monthly Report on Share Purchases and Sales in December 2024 Actions Sale Redemption Fleury Michon December 2024
BRIEF published on 01/13/2025 at 09:00, 1 year 3 months ago Fleury Michon : Déclaration des droits de vote au 31 décembre 2024 Droits De Vote Capital Social AMF 2024 Fleury Michon
BRIEF published on 01/13/2025 at 09:00, 1 year 3 months ago Fleury Michon: Declaration of voting rights as of December 31, 2024 Share Capital Voting Rights AMF 2024 Fleury Michon
BRIEF published on 01/13/2025 at 08:35, 1 year 3 months ago Nomination de Philippe Doublet au Comité exécutif d'Edenred Edenred Comité Exécutif Transformation Digitale Nomination Philippe Doublet
BRIEF published on 01/13/2025 at 08:35, 1 year 3 months ago Philippe Doublet Joins Edenred's Executive Committee Digital Transformation Technology Leadership International Experience Philippe Doublet Edenred Executive
BRIEF published on 01/13/2025 at 08:30, 1 year 3 months ago Gold Terra's Bold 3,000-Meter Drill: A Game Changer for Junior Explorers Con Mine Gold Terra Gerald Panneton Drilling Strategy Junior Explorer
BRIEF published on 01/13/2025 at 08:30, 1 year 3 months ago Le forage audacieux de 3 000 mètres de Gold Terra : une révolution pour les jeunes explorateurs Terre D'or Avec Le Mien Gerald Panneton Stratégie De Forage Explorateur Junior
BRIEF published on 01/13/2025 at 08:25, 1 year 3 months ago METAVISIO Partners with ARC Group for NASDAQ or NYSE Listing Nasdaq Listing Technology Expansion Metavisio IPO Strategy ARC Group
BRIEF published on 01/13/2025 at 08:25, 1 year 3 months ago METAVISIO s'associe au groupe ARC pour une cotation au NASDAQ ou au NYSE Expansion Technologique Metavisio Stratégie D'introduction En Bourse Cotation Au Nasdaq Groupe ARC
BRIEF published on 01/13/2025 at 08:22, 1 year 3 months ago Heidelberg Pharma Advances HDP-101 in Phase I/IIa Study HDP-101 Multiple Myeloma Phase I/IIa Study Antibody Drug Conjugates Clinical Advancement
Published on 04/21/2026 at 01:05, 3 hours 23 minutes ago Boron One Holdings Inc. Announces Closing of Financing
Published on 04/21/2026 at 00:00, 4 hours 28 minutes ago LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
Published on 04/20/2026 at 23:50, 4 hours 38 minutes ago Waskahigan Oil & Gas Corp. Provides Corporate Update
Published on 04/20/2026 at 22:15, 6 hours 13 minutes ago Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Published on 04/20/2026 at 15:25, 13 hours 3 minutes ago Banyan Gold Announces $46.5 Million Private Placement
Published on 04/21/2026 at 02:05, 2 hours 23 minutes ago Remi Preemptively Deploys Programmable Compliance Architecture, Fully Aligned with HKMA's Latest Stablecoin Licensing Standards
Published on 04/20/2026 at 22:05, 6 hours 23 minutes ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 11 mai 2026 - Mise à disposition des documents préparatoires
Published on 04/20/2026 at 22:05, 6 hours 23 minutes ago Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Published on 04/20/2026 at 19:00, 9 hours 28 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 13 avril 2026 au 17 avril 2026
Published on 04/20/2026 at 18:59, 9 hours 29 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 04/20/2026 at 20:44, 7 hours 44 minutes ago ENGIE - Implementation of share buyback programme
Published on 04/20/2026 at 20:44, 7 hours 44 minutes ago ENGIE - Mise en œuvre de son programme de rachat d'actions
Published on 04/20/2026 at 20:01, 8 hours 27 minutes ago TERACT - Approval by the AMF of the public buy out offer followed by a squeeze-out of TERACT shares
Published on 04/20/2026 at 20:01, 8 hours 27 minutes ago TERACT - Communiqué TERACT mise à disposition NR et DAI
Published on 04/20/2026 at 20:01, 8 hours 27 minutes ago TERACT - Approbation par l’AMF de l’offre publique de retrait suivie d’un retrait obligatoire sur les titres de TERACT
